Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_assertion type Assertion NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_head.
- NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_assertion description "[Before therapy, the plasma insulin-like growth factor II (IGF-II) level measured by RIA was elevated (1879 and 1084 micrograms/L; normal range, 358-854 micrograms/L), the serum GH response to hypoglycemia was impaired, and the plasma IGF-I level was low in both patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_provenance.
- NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_assertion evidence source_evidence_literature NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_provenance.
- NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_assertion SIO_000772 2646313 NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_provenance.
- NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_assertion wasDerivedFrom befree-20140225 NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_provenance.
- NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_assertion wasGeneratedBy ECO_0000203 NP521136.RATv3abMnnTNpILK95U5QUbGDkkzAJbd1fEB5CKtq7hXw130_provenance.